The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Saliva-based detection of oral HPV and oral cancer.
 
Evgeny Izumchenko
Stock and Other Ownership Interests - OrisDX
 
Vasudha Mishra
No Relationships to Disclose
 
Claudia Wing
No Relationships to Disclose
 
Xiangying Cheng
No Relationships to Disclose
 
Alexander T. Pearson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics
Research Funding - Abbvie (Inst); EMD Serono (Inst); Kura Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Ari Joseph Rosenberg
Stock and Other Ownership Interests - Galectin Therapeutics; Privo Technologies
Consulting or Advisory Role - Astellas Pharma; Eisai; EMD Serono; Nanobiotix; Novartis; Regeneron; Vaccitech
Speakers' Bureau - Coherus Biosciences
Research Funding - Abbvie (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene (Inst); EMD Serono (Inst); Hookipa Biotech (Inst); Purple Biotech (Inst)
 
Chetan Bettegowda
Stock and Other Ownership Interests - OrisDx
Consulting or Advisory Role - Bionaut Labs; DePuy Companies; Galectin Therapeutics; Haystack Oncology
 
Nishant Agrawal
Leadership - OrisDX
Stock and Other Ownership Interests - Haystack Oncology; OrisDX; Privo Technologies
Patents, Royalties, Other Intellectual Property - Patent pending for salivary diagnostics to diagnose oral cancer.